AbbVie Inc.'s shares dropped last week due to concerns about the erosion of Humira and despite the company beating revenue and EPS expectations.Humira's global sales fell 36% YoY, but AbbVie's other ...
Source LinkAbbVie Inc.'s shares dropped last week due to concerns about the erosion of Humira and despite the company beating revenue and EPS expectations.Humira's global sales fell 36% YoY, but AbbVie's other ...
Source Link
Comments